share_log

BevCanna Announces Strong Third Quarter 2021 Financial Results

BevCanna Announces Strong Third Quarter 2021 Financial Results

BevCanna宣佈2021年第三季度強勁的財務業績
Businesswire ·  2021/12/01 17:57

Increases revenues by more than 1000 per cent over the comparable quarter of 2020

與2020年可比季度相比,收入增加了1000%以上

VANCOUVER, British Columbia--(BUSINESS WIRE)--BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) ("BevCanna" or the "Company"), an emerging leader in innovative health and wellness beverages and products, today reported its unaudited financial results for the quarter ended September 30, 2021.

加拿大不列顛哥倫比亞省温哥華--(美國商業資訊)--BevCanna Enterprise Inc.(CSE:BIV,Q:BVNNF,FSE:7BC)(以下簡稱“BevCanna”或“公司”)今天公佈了截至2021年9月30日的季度未經審計的財務業績。


Third Quarter Company Highlights (All Amounts Reported in $CAD; Unaudited; prepared in accordance with International Financial Reporting Standards)

第三季度公司要點(所有金額均以加元報告;未經審計;根據國際財務報告準則編制)

  • Delivered revenue growth of over 1,000 per cent to $1.1 million during the quarter ended September 30, 2021, compared to $94,000 comparable quarter of 2020
  • Gross Profit of $356,168 during the quarter ended September 30, 2021, compared to a loss of $40,280 comparable quarter of 2020
  • Cash as of September 30, 2021, of $655,563 compared to $1.0 million as of December 31, 2020
  • Announced a definitive agreement to acquire Embark Health Inc. ("Embark"), a leader in solventless cannabis extraction and enhanced delivery technology, with a focus on the formulation and production of advanced cannabis 2.0 products for the B2B, medical and adult-use markets
  • Obtained product listings and purchase orders from British Columbia Liquor Distribution Branch (BCLDB), Alberta Gaming and Liquor Commission and Ontario Cannabis Store, and successfully shipped product to British Columbia and Ontario. Subsequent to quarter end, the initial shipment of the award-winning Keef Brands line of cannabis-infused beverages to the BCLDB sold out online
  • Announced a definitive agreement with The Tinley Beverage Company Inc. (CSE:TNY, OTCQX:TNYBF) to co-manufacture its award-winning cannabis-infused beverages for the Canadian market
  • BevCanna's Naturo Group announced a supply agreement with B.C. Ministry of Forests to supply B.C. firefighters with custom limited-edition TRACE alkaline waters
  • Announced that its market-leading TRACE line of natural alkaline spring waters will be the official Water Supplier of the Canadian E-Prix/2022 Vancouver E-Prix event, including the highly anticipated Formula E electric car race, part of the ABB FIA Formula E World Championship series
  • 在截至2021年9月30日的季度裏,實現了超過1000%的收入增長,達到110萬美元,而2020年可比季度為9.4萬美元
  • 截至2021年9月30日的季度毛利潤為356,168美元,而2020年可比季度虧損40,280美元
  • 截至2021年9月30日的現金為655,563美元,而截至2020年12月31日的現金為100萬美元
  • 宣佈達成一項最終協議,收購無溶劑大麻提取和增強輸送技術領域的領先者Bookk Health Inc.,專注於為B2B、醫療和成人使用市場配製和生產先進的大麻2.0產品
  • 從不列顛哥倫比亞省酒類分銷分公司(BCLDB)、艾伯塔省博彩和酒類委員會和安大略省大麻商店獲得產品清單和採購訂單,併成功將產品運往不列顛哥倫比亞省和安大略省。季度結束後,BCLDB的獲獎Keef Brands大麻注入飲料系列的首批發貨在網上銷售一空
  • 宣佈與Tinley Beverage Company Inc.(CSE:TNY,OTCQX:TNYBF)達成一項最終協議,共同為加拿大市場生產其屢獲殊榮的注入大麻的飲料
  • BevCanna的Naturo集團宣佈與不列顛哥倫比亞省林業部達成供應協議,向不列顛哥倫比亞省消防員提供定製限量版微量鹼性水
  • 宣佈其市場領先的天然鹼性泉水痕量線將成為加拿大E-Prix/2022年温哥華E-Prix賽事的官方供水供應商,其中包括備受期待的電動方程式E賽車比賽,這是ABB FIA Formula E世界錦標賽系列的一部分

Recent Highlights (Subsequent to Quarter End)

近期亮點(季度末之後)

  • On October 5, 2021, BevCanna's Naturo Group announced that it has finalized an agreement with leading North American wholesaler distributor United Natural Foods, Inc. (UNFI). UNFI Canada will now distribute BevCanna's TRACE line of products to retailers across Canada. The UNFI agreement represents a significant milestone for BevCanna. UNFI Canada is a subsidiary of UNFI, the largest publicly traded wholesale distributor in North America
  • On October 7, 2021, BevCanna announced that it has entered into a white-label agreement with Xebra Brands Ltd., a rising player in the global cannabis beverage sector
  • On October 14, 2021, the Company announced that it has entered into an agreement to manufacture and distribute white-label cannabis beverages for Averi Health Products ("Averi"). Averi is a new adult alternative beverage company founded by Terry Donnelly, former CEO of the award-winning Hill Street Beverage Co.
  • On October 21, 2021, BevCanna announced that it has been granted an amendment to its Health Canada-authorized Cannabis Research License, to include sensory evaluations of cannabis beverages in its product development trials. This update to the License will allow BevCanna to conduct on-site human assessments of the taste, smell, feel and visual appeal of its products in development, opening significant opportunities in the formulation and refinement of BevCanna's products and those of its white-label clients
  • 2021年10月5日,貝弗卡納的Naturo集團宣佈,它已經與北美領先的批發商聯合天然食品公司(United Natural Foods,Inc.)敲定了一項協議。FURI加拿大公司現在將向加拿大各地的零售商分銷BevCanna的TRACE系列產品。夥伴基金的協議對BevCanna來説是一個重要的里程碑。FURI加拿大公司是北美最大的上市批發分銷商FURI的子公司
  • 2021年10月7日,BevCanna宣佈,它已經與全球大麻飲料行業的後起之秀XEBRA Brands Ltd.達成了一項白標協議
  • 2021年10月14日,該公司宣佈達成協議,為Averi保健品(“Averi”)生產和分銷白標大麻飲料。Averi是一家新的成人另類飲料公司,由獲獎的Hill Street Beverage Co.前首席執行官特里·唐納利(Terry Donnelly)創立。
  • 2021年10月21日,BevCanna宣佈,它已獲得加拿大衞生部授權的大麻研究許可證的修正案,將大麻飲料的感官評估納入其產品開發試驗。許可證的這次更新將允許BevCanna對其正在開發的產品的味道、氣味、手感和視覺吸引力進行現場人類評估,為BevCanna及其白標客户的產品的制定和改進提供了重要的機會

Management Commentary

管理評論

"As we closed out the third quarter, we delivered impressive revenue growth of more than 1,000 per cent, achieving $1.1 million in sales, compared to $94,000 in the year ago quarter," commented John Campbell, Chief Financial Officer of BevCanna. "Our third quarter results are further evidence of the Company's continued execution and the impact that our brands are having on the market.

BevCanna首席財務官約翰·坎貝爾評論説:“在第三季度結束時,我們實現了超過1000%的令人印象深刻的收入增長,實現了110萬美元的銷售額,而去年同期為9.4萬美元。”我們第三季度的業績進一步證明了公司的持續執行力以及我們的品牌對市場的影響。

"Our unique and diverse portfolio continues to expand, and with the impending close of our acquisition of Embark, will include an even wider range of adult-use and wellness channels and innovative product categories," continued Mr. Campbell. "We look forward to welcoming Embark and its team and remain laser-focused on our go-forward organic growth, while continuing to pursue complementary acquisitions, with the goal of further diversifying our brand offerings in the health and wellness categories."

坎貝爾先生繼續説:“我們獨特和多樣化的產品組合繼續擴大,隨着我們對Bookk的收購即將完成,我們將包括更廣泛的成人使用和保健渠道以及創新產品類別。”我們期待着歡迎Bookk及其團隊,並繼續專注於我們前進的有機增長,同時繼續尋求互補性收購,目標是進一步使我們在健康和保健類別中的品牌產品多樣化。“

The unaudited consolidated financial statements and Management Discussion and Analysis for the quarter ended September 30, 2021, are available at www.sedar.com.

截至2021年9月30日的季度的未經審計的綜合財務報表以及管理層討論和分析可在www.sedar.com上查閲。

AGM Results: shareholders approved all matters considered at the Company's Annual General and Special Meeting of Shareholders ("AGM") held November 24, 2021.

年度股東大會結果:股東通過了公司2021年11月24日召開的年度股東大會(“年度股東大會”)審議的所有事項。

Voting Results

投票結果

Full details of the matters that were voted on at the AGM of Company shareholders held on November 24, 2021, are set out in the Company's Management Information Circular dated October 25, 2021, which is available on SEDAR.

在2021年11月24日舉行的公司股東年度大會上投票表決的事項的全部細節載於本公司日期為2021年10月25日的管理信息通告,該通告可在SEDAR上查閲。

1. Election of Directors

1.董事選舉

The following persons were elected to serve as directors of the Company, with the outcome of votes being as follows:

下列人士當選為本公司董事,表決結果如下:

Nominee

% of Votes for

% of Votes Withheld

Marcello Leone

97.7%

2.3%

John Campbell

97.8%

2.3%

Martino Ciambrelli

97.7%

2.3%

Phil Fontaine

30.1%

69.9%

William Macdonald

98.53%

1.47%

Howard Blank

98.46%

1.54%

Douglas Mason

98.52%

1.48%

被提名人

得票率:

被扣留的選票百分比

馬塞洛·里昂

97.7%

2.3%

約翰·坎貝爾

97.8%

2.3%

馬蒂諾·錢布雷利

97.7%

2.3%

菲爾·方丹

30.1%

69.9%

威廉·麥克唐納

98.53%

1.47%

霍華德·布蘭克

98.46%

1.54%

道格拉斯·梅森

98.52%

1.48%

2. Appointment of Auditor

2.委任核數師

Dale Matheson Carr-Hilton Labonte LLP (DMCL) has been re-appointed as the auditor of the Company for the ensuing year and the Director were authorized to fix the renumeration.

Dale Matheon Carr-Hilton Labonte LLP(DMCL)已再度獲委任為本公司下一年度的核數師,董事獲授權釐定薪酬。

% Of Votes for

% of Votes Withheld

98.34%

1.66%

得票率:

被扣留的選票百分比

98.34%

1.66%

3. Amendment to Articles

3.修訂章程細則

The Company's shareholders also approved an amendment to the Company's articles to create a new class of preferred shares issuable in series as more particularly described in the Management Information Circular.

公司股東還批准了對公司章程的修訂,以創建一種新的可系列發行的優先股類別,詳情請參閲管理信息通函。

About BevCanna Enterprises Inc.

關於BevCanna企業公司

BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) is a diversified health & wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based, and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing, and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories.

貝夫卡納企業公司(CSE:BEV,Q:BVNNF,FSE:7BC)是一家多元化的保健飲料和天然產品公司。BevCanna為自有品牌和白標客户開發和生產一系列鹼性、植物性和大麻類飲料和補充劑。憑藉數十年創建、製造和分銷在全球範圍內引起消費者共鳴的標誌性品牌的經驗,該團隊在營養食品和注入大麻的飲料類別中展示了無與倫比的專業知識。

Based in British Columbia, Canada, BevCanna owns a pristine alkaline spring water aquifer and a world–class 40,000–square–foot, HACCP certified manufacturing facility, with a bottling capacity of up to 210M bottles annually. BevCanna's extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with #1 U.S. cannabis beverage company Keef Brands.

總部設在加拿大不列顛哥倫比亞省的BevCanna擁有一個純淨的鹼性泉水含水層和一個世界級的4萬平方英尺的HACCP認證製造工廠,每年的裝瓶能力高達2.1億瓶。BevCanna廣泛的分銷網絡包括通過其市場領先的TRACE品牌、其Pure Treatment自然健康和健康電子商務平台、其完全許可的加拿大大麻製造和分銷網絡以及與美國頭號大麻飲料公司Keef Brands的合作伙伴關係,擁有3000多個零售分銷點。

Forward-Looking Disclaimer

前瞻性免責聲明

This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events, or developments that the Company believes, expects, or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding: the prospective synergies between the business of BevCanna and Embark and the business of the Company following the closing of the acquisition of Embark; forecasted revenues of the Company in the fourth quarter of 2021 and for the financial year ended December 31, 2022; future product offerings; the potential benefits of various commercial agreements and partnerships; and other statements regarding the business of the Company. The forward-looking statements reflect management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements.

本新聞稿包含前瞻性陳述。除涉及公司相信、預期或預期未來將發生或可能發生的活動、事件或發展的歷史事實陳述外,所有陳述均為前瞻性陳述。本新聞稿中的前瞻性陳述包括有關以下方面的陳述:完成對Bookk的收購後,BevCanna和Bookk的業務與公司業務之間的預期協同作用;公司在2021年第四季度和截至2022年12月31日的財政年度的預測收入;未來的產品供應;各種商業協議和夥伴關係的潛在好處;以及有關公司業務的其他陳述。前瞻性陳述反映了管理層基於現有信息的當前預期,可能會受到一些風險和不確定因素的影響,這些風險和不確定因素可能導致結果與前瞻性陳述中討論的大不相同。

Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include, among other things: that the CSE may not approve the acquisition of Embark as proposed or at all; that the parties may not be able to satisfy the conditions to closing of the acquisition of Embark; general market conditions; risks associated with the COVID-19 pandemic; and other factors beyond the control of the parties. BevCanna expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law, and the Company does not assume any liability for disclosure relating to any other company mentioned herein.

儘管公司認為前瞻性陳述中固有的假設是合理的,但前瞻性陳述並不能保證未來的業績,因此,由於這些陳述固有的不確定性,不應過分依賴它們。可能導致實際結果或事件與當前預期存在實質性差異的因素包括,但不限於:CSE可能不批准或根本不批准FOUNK收購;雙方可能無法滿足完成收購的條件;一般市場狀況;與新冠肺炎疫情相關的風險;以及其他各方無法控制的因素。除適用法律要求外,BevCanna明確不承擔任何因新信息、未來事件或其他原因而更新或修改任何前瞻性陳述的意圖或義務,公司不承擔任何與本文提及的任何其他公司相關的披露責任。


Contacts
聯繫人

On behalf of the Board of Directors:
John Campbell, Chief Financial Officer and Chief Strategy Officer
Director, BevCanna Enterprises Inc.

我謹代表董事會:
約翰·坎貝爾,首席財務官兼首席戰略官
BevCanna企業公司董事

For investor enquiries, please contact:
Shannon Devine, MZ North America
203-741-8811
BVNNF@mzgroup.us

如有投資者查詢,請聯絡:
香農·迪瓦恩(Shannon Devine),MZ北美
203-741-8811
郵箱:bvnf@mzgroup.us

For media enquiries or interviews, please contact:
Wynn Theriault, Thirty Dash Communications Inc.
416-710-3370
wynn@thirtydash.ca

如欲查詢或接受採訪,請聯絡:
Wynn Theriault,Thirty Dash Communications Inc.
416-710-3370
郵箱:wynn@Thirtydash.ca

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論